Source link : https://newshealth.biz/health-news/liver-function-linked-to-os-benefit-in-liver-cancer/
TOPLINE: In patients with hepatocellular carcinoma (HCC) who received immunotherapy, median overall survival was 20.6 months in those with preserved liver function. Metabolic dysfunction-associated steatotic liver disease, liver function metrics, and presence of varices independently predicted survival outcomes. METHODOLOGY: Recent clinical trials have demonstrated the superiority of immunotherapy-based combinations over multikinase inhibitors in treating HCC. […]
The post Liver Function Linked to OS Benefit in Liver Cancer first appeared on News Health.
—-
Author : News Health
Publish date : 2025-08-13 13:42:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8